Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Janet Mullington, PH.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
completed student projects
Investigation of Factors Affecting Completeness of National Trauma Data Bank Reports
Summer, 06/13/13 - 08/09/13
Effects of Sleep Deprivation on Blood Pressure and Vascular Cellular Adhesion Molecules
Summer/Continuation, 02/01/08 - 06/10/08

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01HL125379 (MULLINGTON, JANET M) Aug 19, 2016 - Jun 30, 2021
    NIH/NHLBI
    Mechanisms underlying the blood pressure lowering effect of sleep extension.
    Role: Principal Investigator
  2. R01HL106782 (MULLINGTON, JANET M) Mar 1, 2011 - Feb 28, 2015
    NIH/NHLBI
    Repeated challenge of insufficient sleep: Effects on endothelial function
    Role: Principal Investigator
  3. R01AG028324 (MULLINGTON, JANET M) Aug 1, 2006 - Jan 31, 2011
    NIH/NIA
    Aging &the inflammatory, metabolic and autonomic response to sleep loss
    Role: Principal Investigator
  4. R01HL075501 (MULLINGTON, JANET M) Sep 30, 2003 - May 31, 2008
    NIH/NHLBI
    Adiposity, BP &the inflammatory response to sleep loss
    Role: Principal Investigator
  5. R01MH060641 (MULLINGTON, JANET M) Dec 1, 1999 - Nov 30, 2005
    NIH/NIMH
    CHRONIC SLEEP RESTRICTION &HUMAN HOST RESPONSE
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Yang H, Haack M, Dang R, Gautam S, Simpson NS, Mullington JM. Heart Rate Variability Rebound Following Exposure to Persistent and Repetitive Sleep Restriction. Sleep. 2018 Nov 17. PMID: 30476269.
    View in: PubMed
  2. Grandner M, Mullington JM, Hashmi SD, Redeker NS, Watson NF, Morgenthaler TI. Sleep Duration and Hypertension: Analysis of > 700,000 Adults by Age and Sex. J Clin Sleep Med. 2018 Jun 15; 14(6):1031-1039. PMID: 29852916.
    View in: PubMed
  3. Yang H, Haack M, Gautam S, Meier-Ewert HK, Mullington JM. Repetitive exposure to shortened sleep leads to blunted sleep-associated blood pressure dipping. J Hypertens. 2017 06; 35(6):1187-1194. PMID: 28169885.
    View in: PubMed
  4. Morgenthaler TI, Dort L, Mullington J. Transparency and Partnership. J Clin Sleep Med. 2017 May 15; 13(5):763. PMID: 28356175.
    View in: PubMed
  5. Morgenthaler TI, Hashmi S, Croft JB, Dort L, Heald JL, Mullington J. High School Start Times and the Impact on High School Students: What We Know, and What We Hope to Learn. J Clin Sleep Med. 2016 12 15; 12(12):1681-1689. PMID: 27855730.
    View in: PubMed
  6. Simpson NS, Diolombi M, Scott-Sutherland J, Yang H, Bhatt V, Gautam S, Mullington J, Haack M. Repeating patterns of sleep restriction and recovery: Do we get used to it? Brain Behav Immun. 2016 Nov; 58:142-151. PMID: 27263430.
    View in: PubMed
  7. Mullington JM, Abbott SM, Carroll JE, Davis CJ, Dijk DJ, Dinges DF, Gehrman PR, Ginsburg GS, Gozal D, Haack M, Lim DC, Macrea M, Pack AI, Plante DT, Teske JA, Zee PC. Developing Biomarker Arrays Predicting Sleep and Circadian-Coupled Risks to Health. Sleep. 2016 Apr 01; 39(4):727-36. PMID: 26951388; PMCID: PMC4791606 [Available on 10/01/16].
    View in: PubMed, PubMed Central
  8. Mullington J, Pack AI, Ginsburg GS. In Pursuit of Sleep-Circadian Biomarkers. Sleep. 2015 Nov 01; 38(11):1665-6. PMID: 26446123; PMCID: PMC4813355.
    View in: PubMed, PubMed Central
  9. Morgenthaler TI, Croft JB, Dort LC, Loeding LD, Mullington JM, Thomas SM. Development of the National Healthy Sleep Awareness Project Sleep Health Surveillance Questions. J Clin Sleep Med. 2015 Sep 15; 11(9):1057-62. PMID: 26235156.
    View in: PubMed
  10. Zee PC, Badr MS, Kushida C, Mullington JM, Pack AI, Parthasarathy S, Redline S, Szymusiak RS, Walsh JK, Watson NF. Strategic opportunities in sleep and circadian research: report of the Joint Task Force of the Sleep Research Society and American Academy of Sleep Medicine. Sleep. 2014 Feb 01; 37(2):219-27. PMID: 24501434; PMCID: PMC3900611.
    View in: PubMed, PubMed Central
  11. Chervin RD, Chesson AL, Benca RM, Greenough GP, O'Hearn DJ, Auckley DH, Littner M, Mullington JM, Malhotra A, Berry RB, Malhotra RK, Schulman DA. Organization and structure for sleep medicine programs at academic institutions: Part 1--current challenges. Sleep. 2013 Jun 01; 36(6):795-801. PMID: 23729918; PMCID: PMC3649818.
    View in: PubMed, PubMed Central
  12. Chesson AL, Chervin RD, Benca RM, Greenough GP, O'Hearn DJ, Auckley DH, Littner M, Mullington JM, Malhotra A, Berry RB, Malhotra RK, Schulman DA. Organization and structure for sleep medicine programs at academic institutions: Part 2--goals and strategies to optimize patient care, education, and discovery. Sleep. 2013 Jun 01; 36(6):803-11. PMID: 23729919; PMCID: PMC3649819.
    View in: PubMed, PubMed Central
  13. Haack M, Serrador J, Cohen D, Simpson N, Meier-Ewert H, Mullington JM. Increasing sleep duration to lower beat-to-beat blood pressure: a pilot study. J Sleep Res. 2013 Jun; 22(3):295-304. PMID: 23171375; PMCID: PMC3582793.
    View in: PubMed, PubMed Central
  14. Solarz DE, Mullington JM, Meier-Ewert HK. Sleep, inflammation and cardiovascular disease. Front Biosci (Elite Ed). 2012 Jun 01; 4:2490-501. PMID: 22652655.
    View in: PubMed
  15. Haack M, Scott-Sutherland J, Santangelo G, Simpson NS, Sethna N, Mullington JM. Pain sensitivity and modulation in primary insomnia. Eur J Pain. 2012 Apr; 16(4):522-33. PMID: 22396081; PMCID: PMC3627385.
    View in: PubMed, PubMed Central
  16. Dushay J, Gao C, Gopalakrishnan GS, Crawley M, Mitten EK, Wilker E, Mullington J, Maratos-Flier E. Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes. Diabetes Care. 2012 Jan; 35(1):4-11. PMID: 22040840; PMCID: PMC3241299.
    View in: PubMed, PubMed Central
  17. Mullington JM, Czeisler CA, Goel N, Krueger JM, Balkin TJ, Johns M, Shaw PJ. Panel discussion: current status of measuring sleepiness. J Clin Sleep Med. 2011 Oct 15; 7(5 Suppl):S22-5. PMID: 22003325; PMCID: PMC3190418.
    View in: PubMed, PubMed Central
  18. Mullington JM, Simpson NS, Meier-Ewert HK, Haack M. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab. 2010 Oct; 24(5):775-84. PMID: 21112025; PMCID: PMC3548567.
    View in: PubMed, PubMed Central
  19. Gabrielle Santangelo, Monika Haack, Norah Simpson, Jennifer Scott-Sutherland, Navil Sethna, Janet M. Mullington. Spontaneous Pain is Elevated in Insomnia and Correlated with Negative Mood and Sleep Duration. Sleep. 2010; ((in press)).
  20. Monika Haack, Gabrielle Santangelo, Norah Simpson, Jennifer Scott-Sutherland, Navil Sethna, Janet M. Mullington. Pain Sensitivity and Modulation in Patients Suffering from Primary Insomnia. Sleep. 2010; ((in press)).
  21. Norah S. Simpson, Ph.D.; Monika Haack, Ph.D.; Janet M. Mullington, Ph.D. Effects of sex and adiposity on IL-6 response to total sleep deprivation. Sleep. 2010; ((in press)).
  22. Mullington JM. Let her sleep...but how much? Sleep. 2009 Jul; 32(7):841-2. PMID: 19639744; PMCID: PMC2706903.
    View in: PubMed, PubMed Central
  23. Mullington, Janet M. Let her sleep…but how much? A commentary on Miller et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. . Sleep. 2009; 32(7).
  24. Haack M, Lee E, Cohen DA, Mullington JM. Activation of the prostaglandin system in response to sleep loss in healthy humans: potential mediator of increased spontaneous pain. Pain. 2009 Sep; 145(1-2):136-41. PMID: 19560866; PMCID: PMC2737342.
    View in: PubMed, PubMed Central
  25. Janet M. Mullington and Mark R. Opp. Chapter 16 Immunology. 2009.
  26. Mullington, Janet M. Immune Function During Sleep and Sleep Deprivation. In: Squire LR (ed.) Encyclopedia of Neuroscience. 2009; 5:103-107.
  27. Mullington, Janet M. . Endocrine Function During Sleep and Sleep Deprivation. In: Squire LR (ed.) Encyclopedia of Neuroscience . 2009; 3:977-980.
  28. Haack, M., Scott-Sutherland, J., Sethna, N., and Mullington, J.M. Clinical Implications of Sleep Loss-Pain Interactions. In: Gilles J. Lavigne, Peter A. Cistulli, and Michael T. Smith, eds. Sleep Medicine for Dentists. 2009; 161-166.
  29. Haack, M., Scott-Sutherland, J., Sethna, N., and Mullington, J.M. Mechanisms of Sleep-Loss Pain Interactions. In: Gilles J. Lavigne, Peter A. Cistulli, and Michael T. Smith, eds. Sleep Medicine for Dentists. 2009.
  30. Haack M, Lee E, Cohen AD, Mullington JM. Activation of the prostaglandin system in response to sleep loss in healthy humans: Potential mediator of increased spontaneous pain. Haack M, Lee E, Cohen AD, Mullington JM (in press). Activation of the prostaglandin system in response to sleep loss in healthy humans: Potential mediator of increased spontaneous pain. Pain. . 2009.
  31. Mullington JM, Haack M, Toth M, Serrador JM, Meier-Ewert HK. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis. 2009 Jan-Feb; 51(4):294-302. PMID: 19110131; PMCID: PMC3403737.
    View in: PubMed, PubMed Central
  32. Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep. 2007 Sep; 30(9):1145-52. PMID: 17910386; PMCID: PMC1978405.
    View in: PubMed, PubMed Central
  33. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006 Jun 12; 203(6):1447-58. PMID: 16702604; PMCID: PMC2118329.
    View in: PubMed, PubMed Central
  34. Casement MD, Broussard JL, Mullington JM, Press DZ. The contribution of sleep to improvements in working memory scanning speed: a study of prolonged sleep restriction. Biol Psychol. 2006 May; 72(2):208-12. PMID: 16384630; PMCID: PMC4120641.
    View in: PubMed, PubMed Central
  35. Haack M, Mullington JM. Sustained sleep restriction reduces emotional and physical well-being. Pain. 2005 Dec 15; 119(1-3):56-64. PMID: 16297554.
    View in: PubMed
  36. Mullington, J., Haack, M and Rifai, N. Cellular adhesion molecules decrease at night during sleep. Sleep. 2005.
  37. Schuld A, Haack M, Hinze-Selch D, Mullington J, Pollmächer T. Experimentelle Untersuchungen der Interaktion Zwischen Schlaf und Immunsystem beim Menschen. Psychother Psych Med. 2005; 55:29-35.
  38. Broughton RJ and Mullington, JM. Polysomnography: Principles and Applications in Sleep and Arousal Disorders. In: Ernst Niedermeyer and Fernando Lopes da Silva, Editors. Electroencephalography: Basic Principles, Clinical Applications, and Related Fields. 2005; 899-936.
  39. Schuld A, Haack M, Hinze-Selch D, Mullington J, Pollmächer T. [Experimental studies on the interaction between sleep and the immune system in humans]. Psychother Psychosom Med Psychol. 2005 Jan; 55(1):29-35. PMID: 15647993.
    View in: PubMed
  40. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM. Reply to the Letter to the Editor: Does non-dipping blood pressure profile contribute to vascular inflammation during sleep deprivation?. J Amer Coll Cardiol. 2004; 44:1530-1531.
  41. Haack M, Pollmächer T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain Behav Immun. 2004 Jul; 18(4):361-7. PMID: 15157953.
    View in: PubMed
  42. Broussard J, Haack M, Serrador J and Mullington JM. Diastolic blood pressure (DBP) and mean arterial blood pressure (MAP) are significantly higher in sleep restricted individuals. J Sleep Res. 2004; 14(S):102.
  43. Mullington JM, Haack M, Rifai N. Cellular adhesion molecules (ICAM and VCAM), E- and P-selectins show diurnal rhythms with nadirs during sleep. J Sleep Res. 2004; 14(S):519.
  44. Haack M, Broussard J, Regan M, Mullington JM. Chronic sleep restriction reduces optimism/sociability in a dose dependent manner. J Sleep Res. 2004; 14(S):296.
  45. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004 Feb 18; 43(4):678-83. PMID: 14975482.
    View in: PubMed
  46. Mullington JM, Chan JL, Van Dongen HP, Szuba MP, Samaras J, Price NJ, Meier-Ewert HK, Dinges DF, Mantzoros CS. Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men. J Neuroendocrinol. 2003 Sep; 15(9):851-4. PMID: 12899679.
    View in: PubMed
  47. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003 Mar 15; 26(2):117-26. PMID: 12683469.
    View in: PubMed
  48. Rogers A.E., Mullington J.M. The Symptomatic Treatment of Narcolepsy. In: M. Perlis and K. Lichstein, editors. Treatment of Sleep Disorders: Principles and Practice of Behavioral Sleep Medicine. 2003; 118-135.
  49. Straub RH, Schuld A, Mullington J, Haack M, Schölmerich J, Pollmächer T. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J Endocrinol. 2002 Nov; 175(2):467-74. PMID: 12429044.
    View in: PubMed
  50. Van Dongen HP, Price NJ, Mullington JM, Szuba MP, Kapoor SC, Dinges DF. Caffeine eliminates psychomotor vigilance deficits from sleep inertia. Sleep. 2001 Nov 01; 24(7):813-9. PMID: 11683484.
    View in: PubMed
  51. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem. 2001 Mar; 47(3):426-30. PMID: 11238292.
    View in: PubMed
  52. Mullington JM, Hinze-Selch D, Pollmächer T. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci. 2001 Mar; 933:201-10. PMID: 12000021.
    View in: PubMed
  53. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol. 2001 Jan; 107(1):165-70. PMID: 11150007.
    View in: PubMed
  54. Mullington J.M., Hinze-Selch D, and Pollmächer T. Mediators of inflammation and their interaction with sleep: Relevance for chronic fatigue and related conditions. In: B.A. Sorg and I.R. Bell eds, The Role of Neural Plasticity in Chemical Intolerance. Annals of the New York Academy of Sciences. 2001; 933:201-210.
  55. Schuld A, Mullington J, Friess E, Hermann DM, Galanos C, Holsboer F, Pollmächer T. Changes in dehydroepiandrosterone (DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. J Clin Endocrinol Metab. 2000 Dec; 85(12):4624-9. PMID: 11134118.
    View in: PubMed
  56. Mullington J, Korth C, Hermann DM, Orth A, Galanos C, Holsboer F, Pollmächer T. Dose-dependent effects of endotoxin on human sleep. Am J Physiol Regul Integr Comp Physiol. 2000 Apr; 278(4):R947-55. PMID: 10749783.
    View in: PubMed
  57. Pollmächer T, Schuld A, Kraus T, Haack M, Hinze-Selch D, Mullington J. Experimental immunomodulation, sleep, and sleepiness in humans. Ann N Y Acad Sci. 2000; 917:488-99. PMID: 11268376.
    View in: PubMed
  58. Pollmächer T, Kraus T, Haack M, Uhr M, Mullington J. Salmonella abortus equi endotoxin does not affect leptin plasma levels in healthy humans. J Infect Dis. 1999 Apr; 179(4):1047-8. PMID: 10068609.
    View in: PubMed
  59. Schuld A, Mullington J, Hermann D, Hinze-Selch D, Fenzel T, Holsboer F, Pollmächer T. Effects of granulocyte colony-stimulating factor on night sleep in humans. Am J Physiol. 1999 Apr; 276(4 Pt 2):R1149-55. PMID: 10198397.
    View in: PubMed
  60. Hinze-Selch D, Becker EW, Stein GM, Berg PA, Mullington J, Holsboer F, Pollmächer T. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology. 1998 Aug; 19(2):114-22. PMID: 9629565.
    View in: PubMed
  61. Hermann DM, Mullington J, Hinze-Selch D, Schreiber W, Galanos C, Pollmächer T. Endotoxin-induced changes in sleep and sleepiness during the day. Psychoneuroendocrinology. 1998 Jul; 23(5):427-37. PMID: 9802118.
    View in: PubMed
  62. Hinze-Selch D, Wetter TC, Zhang Y, Lu HC, Albert ED, Mullington J, Wekerle H, Holsboer F, Pollmächer T. In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology. 1998 Apr; 50(4):1149-52. PMID: 9566413.
    View in: PubMed
  63. Broughton R, Krupa S, Boucher B, Rivers M, Mullington J. Impaired circadian waking arousal in narcolepsy-cataplexy. Sleep Res Online. 1998; 1(4):159-65. PMID: 11382873.
    View in: PubMed
  64. Pollmächer T, Hinze-Selch D, Fenzel T, Kraus T, Schuld A, Mullington J. Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry. 1997 Dec; 154(12):1763-5. PMID: 9396961.
    View in: PubMed
  65. Pollmächer T, Mullington J, Lauer CJ. REM sleep disinhibition at sleep onset: a comparison between narcolepsy and depression. Biol Psychiatry. 1997 Oct 15; 42(8):713-20. PMID: 9325565.
    View in: PubMed
  66. Hinze-Selch D, Mullington J, Orth A, Lauer CJ, Pollmächer T. Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry. 1997 Aug 15; 42(4):260-6. PMID: 9270902.
    View in: PubMed
  67. Pollmächer T, Fenzel T, Mullington J, Hinze-Selch D. The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels. Pharmacopsychiatry. 1997 Jul; 30(4):118-21. PMID: 9271776.
    View in: PubMed
  68. Pollmächer T, Mullington J, Holsboer F, Galanos C. Circadian time structure of septic shock: timing is everything - reply. Journal of Infectious Diseases. 1997; 175:1284.
  69. Pollmãcher T, Hinze-Selch D, Mullington J, Fenzel T, Holsboer F. Smoking affects plasma-soluble interleukin-2 receptor levels in patients with schizophrenia. Arch Gen Psychiatry. 1997 Jan; 54(1):89-90. PMID: 9006405.
    View in: PubMed
  70. Mullington J, Broughton R. Does a chronobiologic defect exist in narcolepsy? In: Meier-Ewert K and Okawa M, eds. Sleep-wake disorders. NY:Plenum Publishing, 1997, pgs. 91-104. Does a chronobiologic defect exist in narcolepsy?. In: Meier-Ewert K and Okawa M, eds. Sleep-wake disorders. 1997; 91-104.
  71. Pollmächer T, Mullington J, Korth C, Schreiber W, Hermann D, Orth A, Galanos C, Holsboer F. Diurnal variations in the human host response to endotoxin. J Infect Dis. 1996 Nov; 174(5):1040-5. PMID: 8896506.
    View in: PubMed
  72. Pollmächer T, Hinze-Selch D, Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol. 1996 Oct; 16(5):403-9. PMID: 8889915.
    View in: PubMed
  73. Pollmächer T, Korth C, Schreiber W, Hermann D, Mullington J. Effects of repeated administration of granulocyte colony-stimulating factor (G-CSF) on neutrophil counts, plasma cytokine, and cytokine receptor levels. Cytokine. 1996 Oct; 8(10):799-803. PMID: 8980882.
    View in: PubMed
  74. Mullington J, Hermann D, Holsboer F, Pollmächer T. Age-dependent suppression of nocturnal growth hormone levels during sleep deprivation. Neuroendocrinology. 1996 Sep; 64(3):233-41. PMID: 8875441.
    View in: PubMed
  75. Schuld A, Mullington J, Hermann D, Holsboer F, Pollmächer T. Zirkadiane Schwankungen der primären Wirtsantwort nach Endotoxinapplikation. In: Mayer G, ed. Schlafmedizin in Deutschland, Jahrbuch 1995. 1996; 167-169.
  76. Pollmächer T, Mullington J, Hinze-Selch D, Orth A, Hermann D, Holsboer F. Der Einfluß experimenteller Stimulation der primären Wirtsantwort auf den Schlaf des Menchen. In: Möller HJ, Müller-Spahn F, Kurtz G, eds. Aktuelle Perspektiven der Biologischen Psychiatrie. 1996; 751-754.
  77. Korth C, Mullington J, Schreiber W, Pollmächer T. Influence of endotoxin on daytime sleep in humans. Infect Immun. 1996 Apr; 64(4):1110-15. PMID: 8606066; PMCID: PMC173891.
    View in: PubMed, PubMed Central
  78. Pollmächer T, Korth C, Mullington J, Schreiber W, Sauer J, Vedder H, Galanos C, Holsboer F. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood. 1996 Feb 01; 87(3):900-5. PMID: 8562960.
    View in: PubMed
  79. Hinze-Selch D, Mullington J, Pollmächer T. [Clozapine, cytokines, fever and sleep]. Wien Med Wochenschr. 1996; 146(13-14):311-3. PMID: 9012164.
    View in: PubMed
  80. Hinze-Selch D, Mullington J, Pollmächer T. Sleep during clozapine-induced fever in a schizophrenic patient. Biol Psychiatry. 1995 Nov 15; 38(10):690-3. PMID: 8555381.
    View in: PubMed
  81. Pollmächer T, Hinze-Selch D, Mullington J, Holsboer F. Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors. Arch Gen Psychiatry. 1995 Oct; 52(10):877-8. PMID: 7575109.
    View in: PubMed
  82. Hermann D, Mullington J, Orth A, Korth C, and Pollmächer T. . Morgendliche Endotoxinapplication führt zu vorübergehender Suppression des NonREM-Schlafes bei G-CSF-vorbehandelten Versuchspersonen. In: Mayer G, editor. Schlafmedizin in Deutschland, Jahrbuch 1994. 1995; 299-301.
  83. Pollmächer T, Mullington J. Störungen des Erwachens aus Non-REM-Schlaf. In: Meier-Ewert K, Stefan H, Editors. Anfälle im Schlaf. 1995; 143-150.
  84. Pollmächer T, Mullington J, Korth C, Hinze-Selch D. Influence of host defense activation on sleep in humans. Adv Neuroimmunol. 1995; 5(2):155-69. PMID: 7496610.
    View in: PubMed
  85. Broughton R, Mullington J. Chronobiological aspects of narcolepsy. Sleep. 1994 Dec; 17(8 Suppl):S35-44. PMID: 7701198.
    View in: PubMed
  86. Mullington J, Broughton R. Daytime sleep inertia in narcolepsy-cataplexy. Sleep. 1994 Feb; 17(1):69-76. PMID: 8191205.
    View in: PubMed
  87. Mullington J. Sleepiness and daytime sleep in narcolepsy-cataplexy: chronobiological, napping and performance aspects [Ph.D. Thesis]. 1994.
  88. Mullington J, Broughton R. Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy. Sleep. 1993 Aug; 16(5):444-56. PMID: 8378686.
    View in: PubMed
  89. Broughton R, Mullington J. Circasemidian sleep propensity and the phase-amplitude maintenance model of human sleep/wake regulation. J Sleep Res. 1992 Jun; 1(2):93-98. PMID: 10607032.
    View in: PubMed
  90. Stampi C, Broughton R, Mullington J, Rivers M, Campos JP. Ultrashort sleep strategies during sustained operations: The recuperative value of multiple 80-, 50- and 20-min naps. Shiftwork: Health, sleep and performance. Frankfurt: Peter Lang, 1990:623-8. 1990; 623-628.
  91. Mullington J, Newman J, Dunham W, Broughton R. Phase timing and duration of naps in narcolepsy-cataplexy: preliminary findings. Sleep’90. 1990; 158-160.
  92. Stampi C, Broughton R, Mullington J, Rivers M, Campos J. Ultrashort sleep schedules: Sleep Architecture and recuperative value of 80-, 50-, and 20-min naps. Sleep’90. 1990; 71-74.
  93. Moffitt A, Hoffmann R, Mullington J, Purcell S, Pigeau R, Wells R. Dream psychology: Operating in the dark. Conscious mind, sleeping brain: Perspectives on lucid dreaming. Lucid dreaming. In: Gackenback J, editor. 1988; 429-439.
  94. Mullington J. Cross-state analysis of indices of continuity and cognitive integration in verbal reports of experience [Master’s Thesis]. 1988.
  95. Purcell S, Mullington J, Moffitt A, Hoffmann R, Pigeau R. Dream self-reflectiveness as a learned cognitive skill. Sleep. 1986; 9(3):423-37. PMID: 3764289.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mullington's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (235)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
©2019 President and Fellows of Harvard College
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.